CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $595,806
- in 1 filing, $596K under 10b5-1 plans
Net −$595,806. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 6 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-29 | SCIASCIA THOMAS Chief Scientific Officer | Sale | −53,368 | $2.55 | $136K | 214,433 |
| 2024-05-29 | SCIASCIA THOMAS Chief Scientific Officer | Option exercise · Stock Option (right to buy) | −59,354 | 0 | ||
| 2024-02-15 | SCIASCIA THOMAS Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +150,000 | 150,000 | ||
| 2023-02-16 | SCIASCIA THOMAS Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +187,500 | 187,500 | ||
| 2022-09-19 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Performance Stock Options (right to buy) | +7,500 | 37,500 | ||
| 2022-06-29 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Performance Stock Options (right to buy) | +30,000 | 30,000 | ||
| 2022-02-11 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2022-02-11 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +110,000 | 110,000 | ||
| 2021-02-17 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2020-02-13 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 | ||
| 2019-06-03 | SCIASCIA THOMAS Chief Medical Officer | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-05-09 | SCIASCIA THOMAS Chief Medical Officer | Conversion | +17,118 | 193,724 | ||
| 2019-05-09 | SCIASCIA THOMAS Chief Medical Officer | Conversion · Series A Preferred Stock | −109,015 | 0 | ||
| 2019-05-09 | SCIASCIA THOMAS Chief Medical Officer | Conversion · Series C Preferred Stock | −13,410 | 0 |
Page 2 of 2 · 34 trades